LB
Lawrence Biegelsen Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Becton Dickinson
BDX
$54.8B
| $191.26 | $184 |
4%
downside
| Equal-Weight | 27 days ago |
|
2
Insulet
PODD
$24.4B
| $346.47 | $350 |
1%
upside
| Overweight | 27 days ago |
|
3
Abbott
ABT
$231B
| $132.81 | $142 |
7%
upside
| Overweight | 1 month ago |
|
4
Neuropace
NPCE
$318M
| $9.61 | $20 |
108%
upside
| Overweight | 1 year ago |
|
5
Tandem Diabetes Care
TNDM
$837M
| $12.39 | $82 |
562%
upside
| Overweight | 3 years ago |
|
6
Teleflex
TFX
$5.7B
| $129.09 | $248 |
92%
upside
| Equal-Weight | 3 years ago |
|
7
Intuitive Surgical
ISRG
$163B
| $454.52 | $339 |
25%
downside
| Overweight | 3 years ago |
|
8
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $111 |
6%
upside
| Underweight | 3 years ago |
|
9
DexCom
DXCM
$31.7B
| $80.76 | $143.75 |
78%
upside
| Overweight | 3 years ago |
|
10
Glaukos
GKOS
$5.17B
| $90.14 | $56 |
38%
downside
| Equal-Weight | 3 years ago |
|
11
Merit Medical Systems
MMSI
$5.46B
| $92.15 | $74 |
20%
downside
| Equal-Weight | 3 years ago |
|
12
Edwards Lifesciences
EW
$47.5B
| $80.96 | $76.67 |
5%
downside
| Equal-Weight | 5 years ago |
|
13
NovoCure
NVCR
$1.34B
| $11.98 | $90 |
651%
upside
| Overweight | 5 years ago |
|